PA
ABBV icon

PSI Advisors’s AbbVie ABBV Stock Holding History

PSI Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Buy
3,932
+214
+6% +$46K 0.23% 64
2026
Q1 		$809K Sell
3,718
-54
-1% -$12K 0.19% 68
2025
Q4 		$862K Sell
3,772
-16
-0.4% -$3.65K 0.22% 63
2025
Q3 		$877K Sell
3,788
-84
-2% -$17.1K 0.23% 55
2025
Q2 		$719K Sell
3,872
-230
-6% -$42.7K 0.35% 38
2025
Q1 		$859K Buy
4,102
+267
+7% +$51.9K 0.28% 50
2024
Q4 		$681K Buy
3,835
+1
+0% +$184 0.2% 63
2024
Q3 		$757K Sell
3,834
-69
-2% -$12.9K 0.22% 69
2024
Q2 		$669K Buy
3,903
+77
+2% +$12.8K 0.21% 68
2024
Q1 		$697K Sell
3,826
-655
-15% -$113K 0.25% 64
2023
Q4 		$694K Buy
4,481
+71
+2% +$10.4K 0.26% 69
2023
Q3 		$657K Buy
4,410
+231
+6% +$33.9K 0.28% 63
2023
Q2 		$563K Sell
4,179
-427
-9% -$62.6K 0.25% 70
2023
Q1 		$734K Buy
4,606
+193
+4% +$29.5K 0.35% 55
2022
Q4 		$713K Sell
4,413
-12,963
-75% -$1.99M 0.38% 51
2022
Q3 		$2.33M Sell
17,376
-6,264
-26% -$899K 1.23% 20
2022
Q2 		$3.62M Sell
23,640
-2,694
-10% -$412K 1.78% 11
2022
Q1 		$4.27M Sell
26,334
-363
-1% -$52.7K 1.76% 15
2021
Q4 		$3.62M Buy
26,697
+696
+3% +$82.2K 1.47% 15
2021
Q3 		$2.81M Buy
26,001
+2,140
+9% +$245K 1.29% 20
2021
Q2 		$2.69M Buy
23,861
+1,117
+5% +$126K 1.42% 20
2021
Q1 		$2.46M Buy
22,744
+15,621
+219% +$1.67M 1.45% 19
2020
Q4 		$763K Buy
7,123
+4,133
+138% +$397K 0.53% 42
2020
Q3 		$261K Buy
+2,990
New +$281K 0.2% 94
2020
Q1 		– Sell
-558
Closed -$49K – 109
2019
Q4 		$49K Buy
+558
New +$46.3K 0.03% 265

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PSI Advisors's ABBV Position: Q2 2026 in Review

PSI Advisors increased its AbbVie (ABBV) stake by 5.8% in Q2 2026, buying an estimated $46K and bringing the position to 3,932 shares worth $989K. The position accounts for 0.23% of the portfolio, ranked #64.

PSI Advisors first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.27M in Q1 2022. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PSI Advisors held 3,932 shares of AbbVie worth $989K as of Q2 2026.
  • PSI Advisors bought 214 AbbVie shares in Q2 2026, an estimated $46K.
  • AbbVie made up 0.23% of PSI Advisors's portfolio in Q2 2026, its #64 holding.
  • PSI Advisors first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • PSI Advisors's AbbVie position peaked at $4.27M in Q1 2022.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PSI Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.